View and download slide summaries of the latest original articles focusing on cytokine signalling therapies within rheumatoid arthritis. All materials produced by the CSF team are subsequently reviewed and approved by individual Steering Committee members.
Confronto Degli Effetti Di Baricitinib E Tocilizumab Sull'attività Di Malattia In Pazienti Con Artrite Reumatoide: Un'analisi Di Propensity Score Matching.
Clin Rheumatol. 2021 Jun 16. DOI: 10.1007/s10067-021-05815-3The influence of inflammation on patient global assessment (PGA) improvements differs between baricitinib and tocilizumab differs. Adequate PGA improvement remains one of the unmet needs in current RA treatment.Asai, et al. compared the effects of baricitinib and tocilizumab on disease activity in patients with RA while investigating the influence of inflammation on PGA improvement.Using data from a multicentre registry, 48 propensity-matched pairs of patients, who had been observed for longer t...